Compass Financial Management LLC Makes New $568,000 Investment in CVS Health Corporation $CVS

Compass Financial Management LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,476 shares of the pharmacy operator’s stock, valued at approximately $568,000.

Several other institutional investors and hedge funds have also modified their holdings of CVS. BlackRock Inc. bought a new stake in CVS Health in the 2nd quarter valued at about $12,747,462,000. Norges Bank acquired a new stake in shares of CVS Health in the fourth quarter valued at approximately $1,666,265,000. Wellington Management Group LLP boosted its stake in shares of CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after buying an additional 12,233,675 shares during the period. Pzena Investment Management LLC acquired a new stake in CVS Health during the second quarter worth approximately $1,217,558,000. Finally, Bank of New York Mellon Corp bought a new position in CVS Health during the 2nd quarter worth $932,454,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent analyst reports. Morgan Stanley upped their target price on CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. Bank of America raised their target price on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Argus upped their price target on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. Finally, UBS Group increased their price target on shares of CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Stock Performance

Shares of CVS Health stock opened at $93.01 on Monday. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The business has a 50 day moving average price of $102.02 and a 200-day moving average price of $88.95. The company has a market cap of $118.96 billion, a PE ratio of 24.61, a price-to-earnings-growth ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.